Asia-Pacific Agricultural Biologicals Testing Market

Asia-Pacific Agricultural Biologicals Testing Market Size, Growth, Trends and Forecast:

Asia-Pacific Agricultural Biologicals Testing Market has been estimated at USD 191.82 Million in 2021 and is projected to reach USD 303.92 Million by 2026, at a CAGR of 10.7 % during the forecast period from 2022 - 2027. The Agricultural Biologicals Testing market is showcasing significant potential in the mentioned forecast period.

Agricultural biologicals are typically topical or seed treatment products produced using or containing natural materials, which can complement or replace Agricultural chemical products. They shield crops from pest, weeds and sicknesses and keep crops Healthy. Biological Testing means to find efficacy, toxicity, stability and concentrations of natural materials before letting them into the field.

Asia-Pacific Agricultural Biologicals Testing Market Drivers:

Some of the factors like high production of organic crops, use of stringent regulation policies in agriculture, and increased expenditure on R&D by biological product manufacturers are primarily driving the growth of the market.

Asia-Pacific Agricultural Biologicals Testing Market Segmentation:

Asia-Pacific Agricultural Biologicals Testing Market - By Product Type:

• Bio Stimulants

• Biofertilizers
• Bio Pesticides

Asia-Pacific Agricultural Biologicals Testing Market - By Application:

• Regulatory
• Analytical
• Field Support

Asia-Pacific Agricultural Biologicals Testing Market - By End User:

• Government Agencies
• Biological Product Manufacturers
• Other End users

Geographical Analysis:

On the basis of geography, the Asia-Pacific market is analyzed under various regions namely

• China
• India
• Australia
• Japan
• South Korea

Major Key Players:

The major companies dominating the market share include Eurofins Scientific SE, RJ Hill Laboratories Ltd., SynTech Research, Biotechnologies BT, SGS S.A., Staphyt SA, I2L Research, Anadiag Group, Laus GmbH, Apal Agricultural Laboratory, and Bionema Limited.